Contineum Therapeutics In... (CTNM)
NASDAQ: CTNM
· Real-Time Price · USD
4.33
0.04 (0.93%)
At close: Jun 17, 2025, 10:22 AM
Contineum Therapeutics Class A Common Stock Revenue
Contineum Therapeutics Class A Common Stock reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending March 31, 2025, Contineum Therapeutics Class A Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
41
Market Cap
112.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|